These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9207704)

  • 21. Management of a case of neuroleptic malignant syndrome with bromocriptine.
    Zubenko G; Pope HG
    Am J Psychiatry; 1983 Dec; 140(12):1619-20. PubMed ID: 6650696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The autonomic dysfunction syndrome: aetiology and treatment.
    Rossitch E; Bullard DE
    Br J Neurosurg; 1988; 2(4):471-8. PubMed ID: 3077053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapy of neuroleptic malignant syndrome.
    Lazarus A
    Psychiatr Dev; 1986; 4(1):19-30. PubMed ID: 3703852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathophysiology of parkinsonism due to hydrocephalus.
    Racette BA; Esper GJ; Antenor J; Black KJ; Burkey A; Moerlein SM; Videen TO; Kotagal V; Ojemann JG; Perlmutter JS
    J Neurol Neurosurg Psychiatry; 2004 Nov; 75(11):1617-9. PubMed ID: 15489399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Akinetic mutism and parkinsonism after multiple shunt failure: case report and literature review.
    Rebai RM; Houissa S; Mustapha ME; Azzouni H; Assaggaf S
    J Neurol Surg A Cent Eur Neurosurg; 2012 Sep; 73(5):341-6. PubMed ID: 21445822
    [No Abstract]   [Full Text] [Related]  

  • 26. Dystonia-Parkinson syndrome: differential effects of levodopa and dopamine agonists.
    Klawans HL; Paleologos N
    Clin Neuropharmacol; 1986; 9(3):298-302. PubMed ID: 3719575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathological hypersexuality induced by dopamine replacement therapy in a patient with progressive supranuclear palsy.
    Kim YY; Park HY; Kim JM; Kim KW
    J Neuropsychiatry Clin Neurosci; 2008; 20(4):496-7. PubMed ID: 19196941
    [No Abstract]   [Full Text] [Related]  

  • 28. Parkinsonism and midbrain dysfunction after shunt placement for obstructive hydrocephalus.
    Yomo S; Hongo K; Kuroyanagi T; Kobayashi S
    J Clin Neurosci; 2006 Apr; 13(3):373-8. PubMed ID: 16542840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoamine oxidase inhibitors and Sinemet in Shy-Drager syndrome.
    Rae-Grant A; Young GB; Spence JD
    Neurology; 1985 Jul; 35(7):1085-6. PubMed ID: 4010957
    [No Abstract]   [Full Text] [Related]  

  • 30. Ventriculoperitoneal shunt surgery and the risk of shunt infection in patients with hydrocephalus: long-term single institution experience.
    Reddy GK; Bollam P; Caldito G
    World Neurosurg; 2012 Jul; 78(1-2):155-63. PubMed ID: 22120565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relief of akinetic mutism from obstructive hydrocephalus using bromocriptine and ephedrine. Case report.
    Anderson B
    J Neurosurg; 1992 Jan; 76(1):152-5. PubMed ID: 1727155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Semiology of ventriculoperitoneal shunting dysfunction in children - a review].
    Neiter E; Guarneri C; Pretat PH; Joud A; Marchal JC; Klein O
    Neurochirurgie; 2016 Feb; 62(1):53-9. PubMed ID: 26657112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Restless legs syndrome.
    Feigen A
    JAMA; 1995 Oct; 274(15):1191-2. PubMed ID: 7563499
    [No Abstract]   [Full Text] [Related]  

  • 34. Fatal cerebral hemorrhage due to autonomic dysreflexia in a tetraplegic patient: case report and review.
    Eltorai I; Kim R; Vulpe M; Kasravi H; Ho W
    Paraplegia; 1992 May; 30(5):355-60. PubMed ID: 1598177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Akinetic mutism related to hydrocephalus and cerebellar surgery treated with bromocriptine and ephedrine. A pathophysiological review].
    Mateo-Sierra O; Gutiérrez FA; Fernández-Carballal C; Pinilla D; Mosqueira B; Iza B; Carrillo R
    Neurocirugia (Astur); 2005 Apr; 16(2):134-41; discussion 141. PubMed ID: 15915303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Congenital hydrocephalus and ventriculoperitoneal shunts: influence of etiology and programmable shunts on revisions.
    Notarianni C; Vannemreddy P; Caldito G; Bollam P; Wylen E; Willis B; Nanda A
    J Neurosurg Pediatr; 2009 Dec; 4(6):547-52. PubMed ID: 19951042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The alteration of autonomic function in multiple organ dysfunction syndrome.
    Schmidt H; Hoyer D; Wilhelm J; Söffker G; Heinroth K; Hottenrott K; Said SM; Buerke M; Müller-Werdan U; Werdan K
    Crit Care Clin; 2008 Jan; 24(1):149-63, ix. PubMed ID: 18241783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is stereotactic surgical treatment still necessary for Parkinson's disease in the contemporary trend of medical therapy with dopamine receptor agonist?
    Amano K; Takakura K
    Stereotact Funct Neurosurg; 1997; 69(1-4 Pt 2):5-18. PubMed ID: 9711730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ventriculoperitoneal shunt surgery outcome in adult transition patients with pediatric-onset hydrocephalus.
    Reddy GK; Bollam P; Caldito G; Guthikonda B; Nanda A
    Neurosurgery; 2012 Feb; 70(2):380-8; discussion 388-9. PubMed ID: 21841526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroleptic malignant syndrome associated with the use of carbidopa/levodopa for dystonia in persons with cerebral palsy.
    Perry D; Birthi P; Salles S; McDowell S
    PM R; 2012 May; 4(5):383-4. PubMed ID: 22613365
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.